|
|
| A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
OPA1 DNA Sequencing Test (optic atrophy)
Test Code901115
CPT Codes
81407<br /> Restricted Client Code
Physician Attestation of Informed Consent
This germline genetic test requires physician attestation that patient consent has been received if ordering medical facility is located in AK, DE, FL, GA, IA, MA, MN, NV, NJ, NY, OR, SD or VT or test is performed in MA.
Preferred Specimen
8 mL whole blood collected in two EDTA (lavender-top) tubes
Pediatric (0-3 years): 2 mL
Pediatric (0-3 years): 2 mL
Minimum Volume
6 mL • 1 mL pediatric
Instructions
Informed consent is required.
Please label each specimen tube with two forms of patient identification. These forms of identification must also appear on the requisition form.
Note: Higher blood volumes ensure adequate DNA quantity, which varies with WBC, specimen condition, and need for confirmatory testing. Patients, 0-3 years have higher WBC, yielding more DNA per mL of blood.
Please label each specimen tube with two forms of patient identification. These forms of identification must also appear on the requisition form.
Note: Higher blood volumes ensure adequate DNA quantity, which varies with WBC, specimen condition, and need for confirmatory testing. Patients, 0-3 years have higher WBC, yielding more DNA per mL of blood.
Transport Temperature
Room temperature
Specimen Stability
Room temperature: 10 days
Refrigerated: 10 days
Frozen: Unacceptable
Refrigerated: 10 days
Frozen: Unacceptable
Methodology
Sanger Sequencing
FDA Status
This test was developed and its analytical performance characteristics have been determined by Athena Diagnostics. It has not been cleared or approved by FDA. This assay has been validated pursuant to the CLIA regulations and is used for clinical purposes.
Setup Schedule
Set up: Varies; Report available: 14-28 days
Reference Range
No mutations detected
Clinical Significance
Detects pathogenic variants in the OPA1 gene that are associated with autosomal dominant optic atrophy. This disorder presents in childhood with progressive loss of visual acuity that is usually bilateral, centrocecal scotoma that is typically symmetrical, and bilateral temporal atrophy of the optic nerve. There is considerable variability of clinical presentation both within and between families with visual acuity declining slowly with age in some families, but not others.
